by Kaitlyn Spees
“Today, the U.S. Food and Drug Administration approved Vowst, the first fecal microbiota product that is taken orally.
Vowst is approved for the prevention of recurrence of Clostridioides difficile (C. difficile) infection (CDI)
in individuals 18 years of age and older, following antibacterial treatment for recurrent CDI.”
Hope their gut anguish is
Scoff though folks may about
Finally C. diff’s the
One on the run.